Japan Dermatological Therapeutics Market Analysis

Japan Dermatological Therapeutics Market Analysis

$ 3999

Japan Dermatological Therapeutics Market is at around $2.56 Bn in 2023 and is projected to reach $4.71 Bn in 2030, exhibiting a CAGR of 9.1% during the forecast period. The market is being driven by an increasing aging population, a growing prevalence of dermatological disorders, and technological advancements in treatment options. The market is dominated by key players like Takeda Pharmaceutical Company Limited (JPN), Shionogi & Co., Ltd. (JPN), Eisai Co., ltd. (JPN), Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, Johnson & Johnson, and GlaxoSmithKline Plc.

ID: IN10JPPH035 CATEGORY: Pharmaceuticals GEOGRAPHY: Japan AUTHOR: Aneri Parekh

Buy Now

Japan Dermatological Therapeutics Market Executive Summary

Japan Dermatological Therapeutics Market is at around $2.56 Bn in 2023 and is projected to reach $4.71 Bn in 2030, exhibiting a CAGR of 9.1% during the forecast period.

The field of dermatological therapeutics deals with the diagnosis, treatment, and management of skin diseases and disorders. The goal of this field is to create efficient therapeutic interventions to treat a variety of dermatological conditions, such as psoriasis, acne, eczema, and skin infections. These interventions may include topical treatments, pharmaceuticals, and procedural methods. The objective is to employ evidence-based therapy strategies to increase overall well-being, reduce symptoms, and improve skin health.

Growing aging populations and a rise in dermatological problems are driving the continuous growth of the Japanese dermatological therapeutics market. The market is growing owing to new treatments and technological advancements, with an emphasis on tailored and focused therapies. To introduce novel dermatological medicines, major businesses are spending on research and development.

In 2023, dermatological treatments generated $40.94 Bn in revenue worldwide. This enormous rise, a sign of a modernizing civilization, is made possible by highly productive industrial processes and cutting-edge technologies. A few of the elements fueling the industry's impressive rise include increasing investment, continuous innovation, and enhanced accessibility.

Takeda holds a substantial market position in the Japanese dermatology treatments market due to its well-established portfolio and robust local presence. The company specializes in cutting-edge treatments for a range of skin ailments, such as acne, psoriasis, and atopic dermatitis. Takeda uses its extensive global research and development network to introduce state-of-the-art dermatology products to the Japanese market. Shionogi & Co., Ltd., and AbbVie are among the company's domestic and international competitors respectively.

Japan dermatological therapeutics market

Market Dynamics

Market Growth Drivers:

Growing Prevalence of Dermatological Disorders: The need for dermatological therapies is driven by an increase in the incidence of dermatological disorders such as psoriasis, acne, atopic dermatitis, and skin cancer.

Technological Developments in Treatment Options: The creation of novel and efficient treatment alternatives as well as improvements in dermatological device technology, is propelling the market.

Growing Aging Population: As people get older, there's generally a rise in the prevalence of aging-related dermatological disorders, which is driving up the need for treatment measures.

Market Restraints:

Regulatory Obstacles: The market's expansion may be impeded by strict laws and drawn-out approval procedures for new dermatological goods. Pharmaceutical companies may have to invest a lot of time and resources to comply with regulatory regulations.

Cultural Factors: Aspects related to culture may influence the adoption and acceptance of specific dermatological treatments. Growth in the market may be impacted by preferences for complementary or alternative medicine over Western medications.

Generic Competition: As dermatological medicine patents expire, generic copies of these medications may become more prevalent, which could result in lower prices and lower profit margins for pharmaceutical corporations.

Healthcare Policies and Regulatory Landscape

The regulatory body that works with the Ministry of Health, Labour, and Welfare in Japan is called the Pharmaceuticals and Medical Devices Agency (PMDA). Sending the required funds and the NDA dossier to the PMDA is required. The PMDA may request more information after examining the NDA dossier. If the PMDA is satisfied with the NDA dossier, they will approve the drug for sale. Japan has an extremely stringent and comprehensive drug approval procedure. It is necessary to submit a New Drug Application (NDA), which is reviewed in-depth. By ensuring that only drugs that meet the highest quality standards are permitted to be supplied, the complexity of drug control in Japan increases.

Competitive Landscape

Key Players:

  • Takeda Pharmaceutical Company Limited (JPN)
  • Shionogi & Co., Ltd. (JPN)
  • Eisai Co., ltd. (JPN)
  • Almirall SA
  • Pfizer Inc.
  • AbbVie Inc.
  • Amgen Inc.
  • Novartis AG
  • Johnson & Johnson
  • GlaxoSmithKline Plc.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Japan Dermatological Therapeutics Market Segmentation

By Type

  • Prescription-based Drugs
  • Over-the-counter Drugs

By Disease

  • Alopecia
  • Herpes
  • Psoriasis
  • Rosacea
  • Skin Cancer
  • Acne
  • Atopic Dermatitis
  • Vitiligo
  • Hidradenitis
  • Other Applications

By Drug Class

  • Anti-infectives
  • Corticosteroids
  • Anti-acne
  • Calcineurin Inhibitors
  • Retinoids
  • Other Drug Classes

By Route of Administration

  • Topical Administration
  • Oral Administration
  • Parenteral Administration

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 22 February 2024
Updated by: Ritu Baliya

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter